BioCentury
ARTICLE | Company News

PerSeptive, Boehringer Mannheim deal

September 11, 1995 7:00 AM UTC

Boehringer Mannheim received a worldwide co-exclusive right, together with PBIO and its agents, to distribute PBIO's POROS chromatography columns. Boehringer will purchase $2 million of the Framingham, Mass., company's common stock at $12.69 per share, and has the option to buy an additional $1 million at the same price over the next two years. ...